Journal article
Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children
The Journal of pediatrics, v 138(1), pp 125-128
2001
PMID: 11148527
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
In a randomized, double-blind controlled trial, 42 children with irritable bowel syndrome (IBS) were given pH-dependent, enteric-coated peppermint oil capsules or placebo. After 2 weeks, 75% of those receiving peppermint oil had reduced severity of pain associated with IBS. Peppermint oil may be used as a therapeutic agent during the symptomatic phase of IBS.
Metrics
Details
- Title
- Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children
- Creators
- Robert M Kline - Hahnemann University HospitalJeffrey J Kline - University of Missouri Health SystemJoan DI PALMA - University of Missouri Health SystemGiulio J Barbero - University of Missouri Health System
- Publication Details
- The Journal of pediatrics, v 138(1), pp 125-128
- Publisher
- Elsevier
- Number of pages
- 4
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Medical College of Pennsylvania and Hahnemann University (1993-1996, 1998-2002)
- Web of Science ID
- WOS:000166478700025
- Scopus ID
- 2-s2.0-0035143084
- Other Identifier
- 991021864559404721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Pediatrics